From March 19-21, 2026, P&F Products & Features was proud to participate in LATAM Valves 2026, one of Latin America’s most prestigious congresses dedicated to cardiac valve therapies and innovations in interventional cardiology. Held alongside a gathering of leading specialists, centers of excellence, researchers, and key opinion leaders from across the region, the event served as a powerful forum for advancing the science and clinical practice of structural heart disease treatment.
As a committed heart valve manufacturer, P&F focuses on improving outcomes for patients with structural heart conditions, and LATAM Valves 2026 represented far more than a conference. It was an opportunity to reinforce our mission: to bring innovative, life-changing therapies to patients who need them most.
The Burden of Tricuspid Regurgitation
To understand why events like LATAM Valves are so critical, it helps to understand the stakes. Tricuspid regurgitation — a condition in which the tricuspid valve fails to close properly, causing blood to flow backward into the right atrium — is one of the most underdiagnosed and undertreated valvular heart diseases in the world. For too long, severe tricuspid regurgitation was considered a secondary concern or simply managed conservatively, leaving many patients without meaningful treatment options.
The real-world data tells a sobering story. Patients diagnosed with severe tricuspid regurgitation face a mortality rate of approximately 14% at one year, and that number climbs to 45–50% within five years. These are not abstract statistics. They represent patients who deserve access to advanced, proven therapies.
Closing the treatment gap for tricuspid regurgitation requires collaboration, education, and investment in next-generation heart valve technologies — precisely the work that brought P&F to LATAM Valves 2026.
Our Team on the Ground
P&F was represented at LATAM Valves 2026 by a dedicated team of specialists committed to fostering dialogue and building relationships within the Latin American medical community. Guilherme Agreli, Ana Sanches, Leonardo Jensen, and Fabiana Gonçalves were on-site throughout the three-day event, engaging with clinicians, researchers, and partners across the region.
Their presence at the congress reflects P&F’s ongoing commitment to the Latin American market — a region where the need for advanced structural heart solutions continues to grow, and where strong partnerships with local medical centers and opinion leaders are essential to driving meaningful change in patient care.
Innovation on Display: The P&F Booth Experience
Throughout the congress, the P&F booth served as a hub for education and discovery. Attendees had the opportunity to explore P&F’s portfolio of heart valve technologies through video presentations and hands-on product demonstrations. Whether a first-time visitor or a long-standing partner, every conversation at the booth was an opportunity to deepen understanding of how our solutions address the most pressing clinical challenges in structural cardiology.
From detailing clinical applications to highlighting the real-world benefits of our innovations, the booth experience was designed to bridge the gap between emerging technology and everyday clinical practice. As a heart valve manufacturer, we believe that informed clinicians are better equipped to identify the right patients and deliver the right therapies — and that starts with access to high-quality education and direct engagement with our products.
Live Case Session: Technology in Action
One of the most anticipated moments of P&F’s participation at LATAM Valves 2026 took place on March 20th, when we hosted a dedicated live case session. Live cases are among the most powerful educational tools available in interventional cardiology — they allow clinicians to observe a real procedure in real time, gaining insight into technique, decision-making, and outcomes that simply cannot be replicated in a lecture hall.
During the session, P&F’s technology was showcased in a live clinical setting, demonstrating its practical application, safety profile, and potential to meaningfully improve patients’ quality of life. For specialists working on the front lines of structural heart disease — including those treating patients with tricuspid regurgitation — this kind of direct, evidence-based demonstration is invaluable.
The session reinforced what we have always believed: that innovation must be demonstrated, not just described. Seeing a therapy performed in a live case builds confidence, encourages adoption, and ultimately gets better treatments to more patients faster.
Strengthening Our Commitment to Latin America
LATAM Valves 2026 was more than a showcase — it was a reaffirmation of P&F’s long-term investment in the Latin American structural cardiology landscape. The relationships forged and deepened over these three days will continue to drive collaboration, research, and ultimately, better outcomes for patients across the region.
As a heart valve manufacturer operating at the intersection of innovation and patient care, P&F understands that progress in treating conditions like tricuspid regurgitation requires sustained effort — scientific rigor, clinical partnership, and a relentless focus on the patients at the center of every conversation. Events like this congress remind us of why that work matters and who it is ultimately for.
Looking Ahead
We are grateful to every specialist, researcher, and partner who visited our booth, attended our live case session, or simply stopped to talk during LATAM Valves 2026. Your passion for advancing cardiac care inspires us to continue pushing the boundaries of what is possible in heart valve technology.
The challenge of tricuspid regurgitation — and structural heart disease more broadly — is real and urgent. But so is our commitment to meeting it. P&F will continue to invest in science, education, and partnerships needed to bring meaningful change to patients in Latin America and beyond.
To learn more about P&F’s portfolio of structural heart solutions and our ongoing work in valve replacement technologies, visit productsandfeatures.com.
